Propofol microdroplet formulations
US5637625A · kind A · utility
51Cited by
4References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 19, 1996 |
| Grant date | Jun 10, 1997 |
| Priority date | — |
| Expiry date | Mar 19, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P23/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Formulations of phospholipid-coated microdroplets of propofol devoid of fats and triglycerides provide chronic sedation over extended periods of time without fat overload. Being free of nutrients that support bacterial growth, these microdroplet formulations are bacteriosatic and bactericidal (e.g. self-sterilizing) and thus have extended shelf life.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.